Skip to main content
OpenTrials
Completed

NCT Number: NCT03065504

Turmeric and Turmeric-containing Tablets and Sebum Production

A noticeably increasing number of patients are asking for naturally based extracts and ingredients as supplementary dermatologic remedies. Patients are seeking natural and cost-effective skin care alternatives in place of prescription medications and procedures. This study will isolate the effects of oral turmeric and assess a combination tablet that includes turmeric on sebum production in healthy subjects.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of California, Davis Dermatology Clinical Trials Unit

Sacramento, California, 95816, United States

About this study

Turmeric (Curcuma longa) is a spice that has been shown to exhibit anti-inflammatory, antimicrobial, antioxidant, anti-neoplastic properties, and even potential to improve mental illnesses. In western herbalism, Turmeric is primarily used as an anti-inflammatory agent. In India, turmeric is used in Ayurvedic medicine for the treatment of acne. It has been used both internally and externally.

Curcumin is a phytochemical derived from turmeric and believed to be one of the key active components of turmeric. Curcumin is reported to have activity as an antibacterial and anti-inflammatory agent and has been used as a paste for skin eruptions and infections. Previous basic science work by Dr. Raja Sivamani's lab has shown that both turmeric and curcumin inhibit lipid synthesis in human sebocytes, the cells responsible for the production of sebum

The goal of this study is to evaluate how ingestion of turmeric and tablets that have a combination of herbs including turmeric may modulate sebum production.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 to 50 years of age, and
  • Subject must be able to read and comprehend study procedures and consent forms.

Exclusion criteria

  • Subject should be generally healthy and have no smoking history in the past one year, and must have no history of diabetes, metabolic syndrome, known cardiovascular disease, malignancy, kidney disease, or chronic steroid use.
  • Subjects who consume more than 6 servings of caffeine per day, such as coffee and energy drinks (example - Red Bull).
  • Subjects with known allergies to herbal ingredients.
  • Subjects with known EKG changes.
  • Those who used topical medications in the past two weeks or systemic antibiotics within one month of starting the study.
  • Subjects who are postmenopausal
  • Those who are pregnant or breastfeeding.
  • Those that are prisoners or cognitively impaired.

Treatment and study plan

Turmeric

Dietary Supplement

Turmeric-containing combination tablet

Dietary Supplement

Placebo tablets

Dietary Supplement

Primary outcomes

  1. Change in facial Sebum production at 4 weeks

    Time frame: 4 weeks

    The investigators will use Sebutapes placed on the forehead to measure facial sebum production for 60 minutes at baseline and after 4 weeks. The tapes will collect the facial sebum produced during that time.

Secondary outcomes

  1. Change from baseline in sebum profile, such as inflammatory markers, at 4 weeks

    Time frame: 4 weeks

Sponsors and collaborators

Lead sponsor

University of California, Davis

Other

Registry information

Official study title

Pilot Study on the Effects of Oral Turmeric and Turmeric-containing Tablets on Sebum Production

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Feb 28, 2017
Registry last updated
Dec 20, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.